MADRIGAL PHARMACEUTICALS INC. - COMMON STOCK
319.58
01-十一月-24 15:59:58
15 分钟延时
股票
+60.24
+23.23%
今日范围
262.85 - 321.19
ISIN
N/A
来源
NASDAQ
-
Madrigal Pharmaceuticals Provides Corporate Updates and Reports Third Quarter 2023 Financial Results
06 11月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences
02 11月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
12 10月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Announces Pricing of $500 Million Public Offering
28 9月 2023 22:30:00 条件 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Announces Proposed Public Offering
28 9月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
14 9月 2023 16:30:00 条件 Nasdaq GlobeNewswire
-
13 9月 2023 09:10:00 条件 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer
11 9月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
08 8月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
17 7月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
22 6月 2023 03:30:00 条件 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Supports International NASH Day on June 8
06 6月 2023 08:00:02 条件 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences
01 6月 2023 08:00:02 条件 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals to Participate in the JMP Securities Life Sciences Conference
11 5月 2023 08:00:02 条件 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Provides Corporate Updates and Reports First Quarter 2023 Financial Results
09 5月 2023 08:00:02 条件 Nasdaq GlobeNewswire
-
18 4月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
23 2月 2023 08:00:02 条件 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences
08 2月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
06 1月 2023 08:00:00 条件 Nasdaq GlobeNewswire